<DOC>
	<DOC>NCT02477514</DOC>
	<brief_summary>The purpose of this study is to assess the effect of steady-state tedizolid phosphate on the single-dose pharmacokinetics of midazolam and rosuvastatin in healthy, adult participants.</brief_summary>
	<brief_title>A Study to Evaluate the Effects of Tedizolid Phosphate on the Pharmacokinetics and Safety of Midazolam and Rosuvastatin (MK-1986-004)</brief_title>
	<detailed_description />
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Skin Diseases, Bacterial</mesh_term>
	<mesh_term>Torezolid phosphate</mesh_term>
	<mesh_term>Torezolid</mesh_term>
	<mesh_term>Oxazolidinones</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>healthy, adult males or females (women of nonchildbearing potential) continuous nonsmokers who have not used nicotinecontaining products for the previous 3 months mentally or legally incapacitated or has significant emotional problems history or presence of clinically significant medical or psychiatric condition or disease history or presence of alcoholism or drug abuse within the past 2 years female participants who are pregnant, lactating, or of childbearing potential donated blood or had significant blood loss within 56 days prior to first dose of study drug plasma donation within 7 days prior to first dose of study drug</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>